These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Low yield of stress imaging in a population-based study of asymptomatic patients after percutaneous coronary intervention. Peterson T; Askew JW; Bell M; Crusan D; Hodge D; Gibbons RJ Circ Cardiovasc Imaging; 2014 May; 7(3):438-45. PubMed ID: 24687040 [TBL] [Abstract][Full Text] [Related]
6. Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease. Gössl M; Faxon DP; Bell MR; Holmes DR; Gersh BJ Circ Cardiovasc Interv; 2012 Aug; 5(4):597-604. PubMed ID: 22896575 [No Abstract] [Full Text] [Related]
7. Ischemia-guided percutaneous coronary intervention for patients with stable coronary artery disease. Kim YH; Park SJ Circ J; 2013; 77(8):1967-74. PubMed ID: 23842075 [TBL] [Abstract][Full Text] [Related]
8. Lower diastolic wall strain is associated with coronary revascularization in patients with stable angina. Choi J; Kang MK; Han C; Hwang SM; Jung SG; Kim HK; Chun KJ; Choi S; Cho JR; Lee N BMC Cardiovasc Disord; 2017 Dec; 17(1):301. PubMed ID: 29284413 [TBL] [Abstract][Full Text] [Related]
9. [Stress Echocardiography in the Assessment of Long-Term Outcomes After Percutaneous Coronary Intervention in Patients With Stable Coronary Heart Disease]. Karpov AY; Elkanova MM; Shitov NV; Botvina VU; Lopukhova VV; Saidova AM Kardiologiia; 2017 Jul; 57(7):13-19. PubMed ID: 29041876 [TBL] [Abstract][Full Text] [Related]
10. The effect of percutaneous coronary revascularization on plasma N-terminal pro-B-type natriuretic peptide levels in stable coronary artery disease. Gupta A; Beig JR; Tramboo NA; Afroze D; Hafeez I; Rather HA Indian Heart J; 2018; 70(2):282-288. PubMed ID: 29716708 [TBL] [Abstract][Full Text] [Related]
11. Revascularization with percutaneous coronary intervention does not affect androgen status in males with chronic stable angina pectoris. Gosai JN; Charalampidis P; Nikolaidou T; Parviz Y; Morris PD; Channer KS; Jones TH; Grech ED Andrology; 2016 May; 4(3):486-91. PubMed ID: 27027684 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stents. Kubo M; Miyoshi T; Oe H; Ohno Y; Nakamura K; Ito H BMC Cardiovasc Disord; 2015 Sep; 15():102. PubMed ID: 26399321 [TBL] [Abstract][Full Text] [Related]
13. Prevention of Periprocedural Myocardial Injury During Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease. Ito S; Kitakaze M Circ J; 2018 Jun; 82(7):1746-1748. PubMed ID: 29769462 [No Abstract] [Full Text] [Related]
14. Percutaneous coronary intervention versus coronary artery bypass graft for stable angina: meta-regression of randomized trials. D'Ascenzo F; Barbero U; Moretti C; Palmerini T; Della Riva D; Mariani A; Omedè P; DiNicolantonio JJ; Biondi-Zoccai G; Gaita F Contemp Clin Trials; 2014 May; 38(1):51-8. PubMed ID: 24657881 [TBL] [Abstract][Full Text] [Related]
15. Percutaneous coronary interventions and bypass surgery in patients with cardiac allograft vasculopathy: a single-center experience. Prada-Delgado O; Estévez-Loureiro R; López-Sainz A; Gargallo-Fernández P; Paniagua-Martín MJ; Marzoa-Rivas R; Barge-Caballero E; Cuenca-Castillo JJ; Castro-Beiras A; Crespo-Leiro MG Transplant Proc; 2012 Nov; 44(9):2657-9. PubMed ID: 23146485 [TBL] [Abstract][Full Text] [Related]
16. Successful revascularization versus medical therapy in diabetic patients with stable right coronary artery chronic total occlusion: a retrospective cohort study. Yan Y; Zhang M; Yuan F; Liu H; Wu D; Fan Y; Guo X; Xu F; Zhang M; Zhao Q; Lyu S Cardiovasc Diabetol; 2019 Aug; 18(1):108. PubMed ID: 31434572 [TBL] [Abstract][Full Text] [Related]
17. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. ; Montalescot G; Sechtem U; Achenbach S; Andreotti F; Arden C; Budaj A; Bugiardini R; Crea F; Cuisset T; Di Mario C; Ferreira JR; Gersh BJ; Gitt AK; Hulot JS; Marx N; Opie LH; Pfisterer M; Prescott E; Ruschitzka F; Sabaté M; Senior R; Taggart DP; van der Wall EE; Vrints CJ; ; Zamorano JL; Achenbach S; Baumgartner H; Bax JJ; Bueno H; Dean V; Deaton C; Erol C; Fagard R; Ferrari R; Hasdai D; Hoes AW; Kirchhof P; Knuuti J; Kolh P; Lancellotti P; Linhart A; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Sirnes PA; Tamargo JL; Tendera M; Torbicki A; Wijns W; Windecker S; ; Knuuti J; Valgimigli M; Bueno H; Claeys MJ; Donner-Banzhoff N; Erol C; Frank H; Funck-Brentano C; Gaemperli O; Gonzalez-Juanatey JR; Hamilos M; Hasdai D; Husted S; James SK; Kervinen K; Kolh P; Kristensen SD; Lancellotti P; Maggioni AP; Piepoli MF; Pries AR; Romeo F; Rydén L; Simoons ML; Sirnes PA; Steg PG; Timmis A; Wijns W; Windecker S; Yildirir A; Zamorano JL Eur Heart J; 2013 Oct; 34(38):2949-3003. PubMed ID: 23996286 [No Abstract] [Full Text] [Related]
18. The ORBITA trial: A point of view. Oliveira VD; Giugni FR; Martins EB; Azevedo DFC; Lima EG; Serrano Júnior CV Rev Assoc Med Bras (1992); 2018 Feb; 64(2):100-103. PubMed ID: 29641663 [TBL] [Abstract][Full Text] [Related]